The C and the D of ABCD β Calcium Channel Blockers & Digoxin
ABCD = the ATRIAL rhythm drugs. Adenosine Β· Beta blockers Β· Calcium channel blockers Β· Digoxin. Part III takes the last two. CCBs calm the couple: HR & BP both drop. Digoxin DIGS β a deeper, stronger squeeze and a slower rate, but it does not drop the blood pressure. That one difference drives most of the test questions on this page.
📄 Simple Nursing original — opens in Drive →
One blocks calcium so the heart stops squeezing so hard and so fast β the other adds calcium inside the cell so it squeezes harder but beats slower.
Calcium CONTRACTS muscle. So when you block calcium from entering the cardiac and vascular smooth-muscle cells, you get the exact opposite: less squeeze, slower conduction, wider vessels.
Given for: Hypertension Β· Tachycardia Β· SVT Β· A-Fib Β· A-Flutter.
The classic stem: βA client in A-Fib is started on diltiazem. Which finding shows the intended effect?β
Answer: Ventricular rate decreased from 160 to the 70s.
Notice what the answer is not: the A-Fib did not convert. Rate control β rhythm conversion. The atria are still fibrillating β you just slowed how many of those impulses get through the AV node.
Digoxin DIGS for a deeper, more forceful contraction and slows the heart rate β so cardiac output goes up while the heart works less. That is why it treats A-Fib and heart failure with the same pill.
| π§± Calcium channel blockers | π Digoxin | |
|---|---|---|
| Examples | Verapamil Β· Diltiazem Β· Amlodipine | Digoxin (cardiac glycoside) |
| Heart rate | β Down | β Down |
| Blood pressure | β Down β vessels relax | Unchanged |
| Contractility | β or neutral | β Up β deeper squeeze |
| Signature side effect | Orthostatic hypotension Β· dizziness on standing | Toxicity β anorexia, N/V, vision changes |
| Signature teaching | Slow position changes | Apical pulse 1 min, hold if <60 |
| Key lab | BP & HR trend | Potassium + digoxin level + creatinine |
| Also used for | HTN, SVT, A-Fib, A-Flutter, tachycardia | A-Fib & heart failure |
CCBs make them dizzy on the way up. Digoxin makes them nauseated, bradycardic and unable to read the newspaper.
Vessels relaxed + rate slowed = the blood pressure cannot catch up when they stand. Dizziness on standing is the priority adverse effect to watch for β because the next step is a fall.
Do not give the next dose if toxicity signs are present β hold it and call the provider.
Max safe = 2.0 ng/mL. Under 2.0 is safe; over 2.0 is toxic. In heart failure many providers aim lower β around 0.5β0.8 ng/mL β so always read the ordered target.
Antidote: digoxin immune Fab (DigiFab) for severe toxicity.
Digoxin and potassium compete for the same site on the sodium-potassium pump. Low potassium = more room for digoxin to bind = toxicity at a βnormalβ level. This is why the diuretic on the same MAR is so dangerous.
So the NCLEX answer to βclient on digoxin can't read her book β what lab do you check?β is the potassium (and the digoxin level). Vision change = toxicity, and low K is what pushed them there.
Digoxin is cleared by the kidneys. Bad kidneys = the drug stacks up = toxicity, even on the same old dose.
A client already on a beta blocker who gets IV verapamil or diltiazem can drop into profound bradycardia, heart block or hypotension.
Hold the dose and clarify the order if the HR is already under 60 or the systolic BP is under 90.
Three sentences the client has to be able to repeat back β and the three test questions built from them.
| Question stem | Answer |
|---|---|
| Intended effect for diltiazem? | Ventricular rate decreased from 160 to the 70s |
| Priority adverse effect for amlodipine? | Dizziness (orthostatic hypotension) |
| Most important teaching for verapamil? | Slow position changes |
| Client on digoxin can't read her book β key lab? | Potassium (with the digoxin level) β low K drives toxicity |